Authors
Latest:
How One CRO Uses RBQM in DCT ImplementationIndustry provides endless methods in crafting solutions for patients.
Latest:
The Importance of NGS Panel CustomizationExplore the pivotal role of Next-Generation Sequencing (NGS) panel customization in driving advancements in oncology research.
Latest:
Rethinking ECOG Scores to Improve Patient Access and Clinical Trials EligibilityRecent study results highlight need for new metrics in ECOG scoring to mitigate variability.
Latest:
The Transformation of Clinical Trials from Writing on Papyrus to the World of TechnologyNew requirements must be put in place to ensure data quality and integrity.
Latest:
Managing Clinical Trials During the COVID PandemicHow one CRO in India quickly implemented processes and technology to mitigate risk
Latest:
New Technology Springs Innovation in Clinical Trials SpaceMany companies have implemented new technologies and are adopting clinical trial models that are more patient-centric.
Latest:
A Global Network to Empower Leaner Oncology Clinical Trials: Unlocking the Potential of Local Genomic Biomarker Testing in EuropeMonday, October 25, 2021 at 10am EDT Attend this webinar to hear about CGP, the latest in onco-innovation for genomic biomarker testing and uncover the role that Illumina and Q2 Solutions are playing in evolving the CGP testing landscape to deliver a localized testing model to support oncology precision medicine clinical trials in Europe. Lastly, the webinar will reveal the updated roadmap of Q2 Solutions’ Edinburgh Genomics laboratory.
Latest:
ePRO and Ensuring Data IntegrityPush for accurate data collection during pandemic led by increased focus on patient engagement.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
The Value of Integrated Data Views for Clinical TrialsTo have a successful integration of data from across clinical systems, a strong understanding of the data is a critical.
Latest:
With Project Optimus, Success Favors the PreparedOncology drug developers must start asking questions in preparation of FDA’s dose optimization initiative.
Latest:
Distribution Network Ensures In-Home Trials and Patients SucceedIndustry must work closely with patients to advance the use of decentralized technology.
Latest:
eConsent: Why Language MattersFostering common eConsent terminologies enriches communication and understanding across all stakeholders.
Latest:
At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ DeviceLaboratory services organization focuses on easing patient and site burden with improved collection device.
Latest:
The Only Thing Certain is the Uncertainty: How to Re-Plan Future Clinical Trial Enrollment in Covid-19 TimesSponsors need to develop a strategy on how to evaluate the impact of the pandemic on the re-start of halted trials.
Latest:
Shifting Expectations for Clinical DevelopmentCOVID-19 speeds up clinical research and creates new advancements within industry.
Latest:
What Stands in the Way of an Efficient CRO-Pharma Collaboration?Survey taken by CROs and pharma/biotech companies seeks answers in maximizing partnership.
Latest:
When Should the Audit Trail Begin?A discussion of the regulatory history behind audit trails and its interpretation as it relates to clinical research data originating or residing in EDC or eCOA systems.
Latest:
Alternatives to Permanent EmployeesHow pharmaceutical start-ups can mitigate risk and avoid costly hiring mistakes.
Latest:
How Pharma Needs to Prepare for the Next PandemicMaster protocols helped accelerate research during the pandemic in the EU. How can US companies learn from this and start preparing master protocols now?
Latest:
Listening at Scale and Leveraging Conversational Data to Improve Clinical RecruitmentHow can managers ensure their clinical trial participants represent future patients?
Latest:
Examining the Current Value of ClinicalTrials.gov Listings for Patients and the PublicLooking beyond regulatory compliance.
Latest:
Characterizing Clinical Data Management Challenges and Their Impact2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.
Latest:
The Current Status of European Research Related to COVID-19: The EUCROF PerspectiveSuccessful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
Latest:
How to Improve Recruitment Rates, Reduce Site Burden, and Avoid Wasted SpendingIn light of Facebook ban on ads targeting patients, industry has chance to reinvent digital advertising for trials.
Latest:
How to Address—and Overcome—Operational Challenges in Master Protocol StudiesTrials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Latest:
Turning Challenges into Opportunities: Evaluation of Digital Health ProductsShiri Diskin, PhD, Head of Medical Writing at Bioforum, sits down with Daphna Laifenfeld, PhD, Chief Scientific Officer at Ibex Medical Analytics to discuss the challenges associated with developing a CER and how to effectively navigate them while creating opportunities that increase efficiencies.
Latest:
Improving Clinical Trial Patient Diversity: Can Central Imaging Play a Role?Centralized medical imaging providers must challenge their current processes to improve patient diversity.
